Brief: Genfit Announces Pivotal Publication Of NIS4 Technology

Genfit SA

05/08/2020 07:38

Aug 5 (Reuters) - Genfit SA  GNFT.PA :
    * GENFIT ANNOUNCES PIVOTAL PUBLICATION OF NIS4™ TECHNOLOGY
TO
IDENTIFY PATIENTS WITH AT-RISK NASH IN LANCET GASTROENTEROLOGY &
HEPATOLOGY
    * INTENDS TO LICENSE NIS4™ TECHNOLOGY TO A MAJOR DIAGNOSTIC
PARTNER TO ENABLE DEVELOPMENT AND PROJECTED LAUNCH OF A CLINICAL
DIAGNOSTIC TEST POWERED BY NIS4™ IN SECOND HALF OF 2020
    * CONTINUES TO EXPLORE OPPORTUNITIES TO OBTAIN FORMAL
MARKETING
AUTHORIZATION OF AN IN VITRO DIAGNOSTIC (IVD) VERSION OF NIS4™
IN BOTH U.S. AND EUROPEAN MARKETS

Source text for Eikon:  ID:nGNE33kXmY 
Further company coverage:  GNFT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))